These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6452721)

  • 21. T-T cell interaction in the induction of delayed-type hypersensitivity (DTH) responses: vaccinia virus-reactive helper T cell activity involved in enhanced in vivo induction of DTH responses and its application to augmentation of tumor-specific DTH responses.
    Takai Y; Kosugi A; Yoshioka T; Tomita S; Fujiwara H; Hamaoka T
    J Immunol; 1985 Jan; 134(1):108-13. PubMed ID: 3155458
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanism involved in the systemic suppression of antigen-presenting cell function by UV irradiation. Keratinocyte-derived IL-10 modulates antigen-presenting cell function of splenic adherent cells.
    Ullrich SE
    J Immunol; 1994 Apr; 152(7):3410-6. PubMed ID: 8144924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antigen- and receptor-driven regulatory mechanisms. X. The induction and suppression of hapten-specific granulomas.
    Ginsburg CH; McCluskey RT; Nepom JT; Takaoki M; Falchuk ZM; Benacerraf B; Greene MI
    Am J Pathol; 1982 Mar; 106(3):421-31. PubMed ID: 6175220
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cellular interactions in the adoptive transfer of contact sensitivity: characterization of an antigen-nonspecific Vicia villosa-adherent T cell needed for adoptive transfer into naive recipients.
    Ptak W; Green DR; Flood P
    J Immunol; 1986 Sep; 137(6):1822-8. PubMed ID: 2943803
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Splenic I-J-bearing antigen-presenting cells in activation of suppression: further characterization.
    Granstein RD; Greene MI
    Cell Immunol; 1985 Mar; 91(1):12-20. PubMed ID: 3155997
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Control of autoimmune responses induced with modified self antigens.
    Naor D; Tarcic N
    Ann N Y Acad Sci; 1982; 392():178-90. PubMed ID: 6215878
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studies on the induction of tolerance to alloantigens. I. The abrogation of potentials for delayed-type-hypersensitivity response to alloantigens by portal venous inoculation with allogeneic cells.
    Qian J; Hashimoto T; Fujiwara H; Hamaoka T
    J Immunol; 1985 Jun; 134(6):3656-61. PubMed ID: 2580893
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel function of DUSP14/MKP6 (dual specific phosphatase 14) as a nonspecific regulatory molecule for delayed-type hypersensitivity.
    Nakano Y
    Br J Dermatol; 2007 May; 156(5):848-60. PubMed ID: 17263825
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The involvement of antigen-presenting cells and suppressor cells in the ultraviolet radiation-induced inhibition of secondary cytotoxic T cell sensitization.
    Jensen PJ
    J Immunol; 1983 May; 130(5):2071-4. PubMed ID: 6220078
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suppression of delayed-type hypersensitivity mediated by macrophage-like cells in mice with experimental liver injury.
    Tajima S; Nishimura N; Ito K
    Immunology; 1985 Jan; 54(1):57-64. PubMed ID: 2982732
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An early component of delayed-type hypersensitivity mediated by T cells and mast cells.
    van Loveren H; Meade R; Askenase PW
    J Exp Med; 1983 May; 157(5):1604-17. PubMed ID: 6602201
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Two phenotypically distinct T cells (Ly1+2- and Ly1-2+) are involved in ultraviolet-B light-induced suppression of the efferent DTH response to HSV-1 in vivo.
    Howie SE; Norval M; Maingay J; Ross JA
    Immunology; 1986 Aug; 58(4):653-8. PubMed ID: 3015783
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of radiation on tumor-specific delayed-type hypersensitivity (DTH) response in mice].
    Kawahara S; Hashimoto T; Hachisu R
    Nihon Igaku Hoshasen Gakkai Zasshi; 1989 May; 49(5):675-80. PubMed ID: 2798059
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phenotypic and immunoregulatory characteristics of monocytic iris cells.
    Li X; Shen S; Urso D; Kalique S; Park SH; Sharafieh R; O'Rourke J; Cone RE
    Immunology; 2006 Apr; 117(4):566-75. PubMed ID: 16556271
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An antigen-specific signal is required for the activation of second-order suppressor T cells in the regulation of delayed-type hypersensitivity to 2,4,6-trinitrobenzene sulfonic acid.
    Tsurufuji M; Benacerraf B; Sy MS
    J Exp Med; 1983 Sep; 158(3):932-45. PubMed ID: 6193239
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ultraviolet light exposure suppresses contact hypersensitivity by abrogating endothelial intercellular adhesion molecule-1 up-regulation at the elicitation site.
    Komura K; Hasegawa M; Hamaguchi Y; Saito E; Kaburagi Y; Yanaba K; Kawara S; Takehara K; Seki M; Steeber DA; Tedder TF; Sato S
    J Immunol; 2003 Sep; 171(6):2855-62. PubMed ID: 12960307
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The delayed-type hypersensitivity response to (4-hydroxy-3-nitrophenyl) acetyl- (NP) coupled proteins is carrier-specific: in vivo and in vitro demonstrations.
    Barry WC; Ruddle NH
    J Immunol; 1983 Jul; 131(1):70-6. PubMed ID: 6190928
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of two different Ly-1+ T cell populations that mediate delayed-type hypersensitivity.
    Van Loveren H; Kato K; Meade R; Green DR; Horowitz M; Ptak W; Askenase PW
    J Immunol; 1984 Nov; 133(5):2402-11. PubMed ID: 6332850
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Delayed-type hypersensitivity initiation by early-acting cells that are antigen mismatched or MHC incompatible with late-acting, delayed-type hypersensitivity effector T cells.
    Ptak W; Herzog WR; Askenase PW
    J Immunol; 1991 Jan; 146(2):469-75. PubMed ID: 1987274
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of 2'-deoxyguanosine upon the development of DTH effector T cells and suppressor T cells in vivo.
    Bril H; van den Akker TW; Molendijk-Lok BD; Bianchi AT; Benner R
    J Immunol; 1984 Feb; 132(2):599-604. PubMed ID: 6228591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.